mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.04 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |